Physician profile
Thomas Hayne
NPI 1376533786
$1,031.89
in general payments reported to CMS, 2019-2025
17 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $107 · 2021: $12.88 · 2022: $63.61 · 2023: $181 · 2024: $187 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $201.18 | 2019-2020 | |
| Pfizer INC. | $180.38 | 2019-2023 | |
| Sanofi Pasteur INC. | $134.44 | 2019-2025 | |
| Glaxosmithkline, LLC. | $104.74 | 2019-2025 | Bexsero, Penmenvy, Shingrix |
| Cranial Technologies, INC | $60.97 | 2020-2024 | Doc Band |
| Supernus Pharmaceuticals, INC. | $55.40 | 2021-2025 | Qelbree |
| Acadia Pharmaceuticals INC | $54.77 | 2025 | Daybue |
| Kaleo, INC. | $44.16 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $39.09 | 2024 | |
| Collegium Pharmaceutical, INC. | $34.34 | 2025 | Jornay Pm |
| Corium, LLC | $31.61 | 2023 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $18.07 | 2020 | |
| Phadia US INC. | $17.68 | 2024 | Immunocap |
| Alk-Abello, INC | $17.24 | 2025 | Neffy |
| Vertical Pharmaceuticals, LLC | $12.86 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.64 | 2019 | |
| Merck Sharp & Dohme LLC | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hayne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.